Prostatic Artery Embolization
GPTKB entity
Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical procedure
|
| gptkbp:alternativeTo |
gptkb:transurethral_resection_of_the_prostate
|
| gptkbp:approvedBy |
FDA (for BPH)
|
| gptkbp:complication |
urinary tract infection
hematuria non-target embolization |
| gptkbp:contraindicationsInclude |
active urinary tract infection
severe atherosclerosis |
| gptkbp:duration |
1-2 hours
|
| gptkbp:firstDescribed |
2000s
|
| gptkbp:followedBy |
clinical assessment
imaging studies |
| https://www.w3.org/2000/01/rdf-schema#label |
Prostatic Artery Embolization
|
| gptkbp:imagingGuidance |
fluoroscopy
angiography |
| gptkbp:improves |
lower urinary tract symptoms
|
| gptkbp:minimallyInvasive |
true
|
| gptkbp:performedAt |
gptkb:hospital
outpatient setting |
| gptkbp:performedBy |
interventional radiologist
|
| gptkbp:performedUnder |
local anesthesia
|
| gptkbp:preserves |
sexual function
|
| gptkbp:reduces |
prostate volume
|
| gptkbp:restored |
short
|
| gptkbp:successRate |
70-90%
|
| gptkbp:usedFor |
gptkb:benign_prostatic_hyperplasia
|
| gptkbp:bfsParent |
gptkb:PAE
|
| gptkbp:bfsLayer |
6
|